Viatris Inc. (Viatris) is a global healthcare company. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The JANZ segment consists of its operations in Japan, Australia and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, as well as the Company’s ARV franchise. Its portfolio comprises over 1,400 approved molecules across a range of key therapeutic areas, including key brands and complex generics. It operates around 40 manufacturing sites worldwide, which produce oral solid doses, injectables, complex dosage forms and active pharmaceutical ingredients. Its products include Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen Auto Injector, Fraxiparine and Yupelri.
|
|
|
|
|
TD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts.
Date | Event description | Earnings per share actual | Earnings estimate range | Previous year's actual |
---|---|---|---|---|
August 7, 2023 | Q2 2023 Earnings Release | $0.75 | $0.68 to $0.75 | $0.88 |
May 8, 2023 | Q1 2023 Earnings Release | $0.77 | $0.65 to $0.72 | $0.93 |
February 27, 2023 | Q4 2022 Earnings Release | $0.67 | $0.55 to $0.944 | $0.80 |
November 7, 2022 | Q3 2022 Earnings Release | $0.87 | $0.79 to $0.93 | $0.99 |
Ex-dividend date | Amount | Record date | Pay date |
---|---|---|---|
August 23, 2023 | $0.12 | August 24, 2023 | September 15, 2023 |
May 23, 2023 | $0.12 | May 24, 2023 | June 16, 2023 |
March 8, 2023 | $0.12 | March 9, 2023 | March 17, 2023 |
November 22, 2022 | $0.12 | November 23, 2022 | December 16, 2022 |
Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.
, , , Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.